Scott Youmans
Chief Tech/Sci/R&D Officer chez IPI LEGACY LIQUIDATION CO
Profil
Scott Youmans is currently the Senior Vice President-Technical Operations at Impel Pharmaceuticals, Inc. Previously, he was the Chief Operating Officer at Atossa Therapeutics, Inc. from 2015 to 2016.
He also held the position of Vice President-Engineering at Pathway Medical Technologies, Inc. Mr. Youmans completed his undergraduate degree at Western Washington University.
Postes actifs de Scott Youmans
Sociétés | Poste | Début |
---|---|---|
IPI LEGACY LIQUIDATION CO | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Scott Youmans
Sociétés | Poste | Fin |
---|---|---|
ATOSSA THERAPEUTICS, INC. | Chief Operating Officer | 12/02/2016 |
Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Pathway Medical Technologies, Inc. develops, manufactures, and markets medical devices intended for the treatment of arterial disease, specifically the peripheral arterial disease. Pathway Medical Technologies was founded in 1998, and is headquartered in Kirkland, WA. | Corporate Officer/Principal | - |
Formation de Scott Youmans
Western Washington University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
IPI LEGACY LIQUIDATION CO | Health Technology |
ATOSSA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Pathway Medical Technologies, Inc. develops, manufactures, and markets medical devices intended for the treatment of arterial disease, specifically the peripheral arterial disease. Pathway Medical Technologies was founded in 1998, and is headquartered in Kirkland, WA. | Health Technology |